| Young
Investigator Symposium : Group A@ 8:30-12:05 |
| YIS-A
Session I |
8:30-10:10 k100l |
Chair:
Keiko Sakai (O-18/ 19/ 20)
Chair: Hayato Murakoshi (O-21/ 22) |
8:30-8:50 y20z |
O-18
-3A |
Md Abu Osman
[Kumamoto University, Japan]
|
M-CSF diminishes anti-HIV-1 activity of cytokines
including IL-32 |
8:50-9:10 y20z |
O-19
-3A |
Kristel Paola Ramirez Valdez
[Kumamoto University, Japan]
|
Can antibodies contribute to controlling infection
with transmitted/founder virus? |
9:10-9:30 y20z |
O-20
-3A |
Chihiro Motozono
[Kinki University, Japan] |
Molecular basis of a dominant T cell response to
an HIV reverse transcriptase epitope presented by the protective allele
HLA-B*51:01 |
9:30-9:50 y20z |
O-21
-3A |
Nozomi Kuse
[Kumamoto University, Japan]
|
Control of HIV-1 by Pol283-8-specific CTLs in HLA-B*51:01+long-term
non progressors |
| 9:50-10:10 y20z |
O-22
-3A |
Xiaoming Sun
[Kumamoto University, Japan] |
Presentation of two HLA-A*24:02-restricted overlapping
epitopes elicit different patterns of CD8 T cell repertoire and select
same escape mutation in HIV-infected patients |
| 10:10-10:25
k15l @@Coffee Break |
| YIS-A
Session II |
10:25-12:05 k100l |
Chair:
Madoka Koyanagi (O-23/ 24)
Chair: Takeo Kuwata (O-25/ 26/ 27) |
10:25-10:45 y20z |
O-23
-3A |
Koji Watanabe
[NCGM, Japan]
|
Cross-clade CD8+ T cell responses in chronically
HIV-1 clade A/E-infected individuals |
10:45-11:05 y20z |
O-24
-3A |
Macdonald Mahiti
[Kumamoto University, Japan]
|
Differential modulation of Nef-mediated downregulation
activity of HLA class I alleles in HIV-1 chronic infection |
11:05-11:25 y20z |
O-25
-3A |
Keiko Sakai
[Kumamoto University, Japan]
|
The lack of a significant impact of HIV-1 Gag replication
capacities on patientsf disease outcomes in a chronically infected,
treatment-naive Japanese cohort |
11:25-11:45 y20z |
O-26
-3A |
Stanley C. Meribe
[Kumamoto University, Japan]
|
Acceleration of disease Progression by a single naturally-arising
polymorphism, within functional region of HIV-1 nef |
| 11:45-12:05 y20z |
O-27
-3A |
Takayuki Chikata
[Kumamoto University, Japan] |
Host-specific adaptation of HIV-1 subtype B in the
Japanese population |
| Young
Investigator Symposium : Group B@ 8:30-12:05 |
| YIS-B
Session I |
8:30-10:10 k100l |
Chair:
Kazuaki Monde (O-28/ 29)
Chair: Masayuki Amano (O-30/ 31/ 32) |
8:30-8:50 y20z |
O-28
-3B |
Shohei Taketomi
[Tokyo Medical and Dental University, Japan]
|
Structure activity relationship studies on a spacer
moiety of small molecular CXCR4 antagonists as potent HIV-1 entry
inhibitors |
8:50-9:10 y20z |
O-29
-3B |
Masayuki Amano
[Kumamoto University, Japan]
|
Discovery of small compounds that induce HIV-1 Capsid
protein degradation. |
9:10-9:30 y20z |
O-30
-3B |
Hironori Hayashi
[Kumamoto University, Japan]
|
The dimerization inhibition mechanism of darunavir
and the dynamics of HIV-1 protease dimerization |
9:30-9:50 y20z |
O-31
-3B |
Amber R. Moore
[Kumamoto University, Japan]
|
Evaluation of HIV-1 reverse transcriptase (RT) heterodimerization
within living cells using bimolecular fluorescence complementation
(BiFC) |
| 9:50-10:10 y20z |
O-32
-3B |
Pedro Miguel Salcedo Gomez
[Kumamoto University, Japan] |
GRL-04810 and GRL-05010; novel difluoride-containing
HIV-1 protease inhibitors (PIs) with potent antiviral activity and
favorable penetration across the blood-brain barrier. |
| 10:10-10:25
k15l@@Coffee Break |
| YIS-B
Session II |
10:25-12:05 k100l |
Chair:
Shigeyoshi Harada (O-33/ 34)
Chair: Koji Watanabe (O-35/ 36/ 37) |
10:25-10:45 y20z |
O-33
-3B |
Kazuhiko Maeda
[Kumamoto University, Japan]
|
Role of mammalian TREX-2 component GANP in HIV-1
infection |
10:45-11:05 y20z |
O-34
-3B |
Muntasir Alam
[Kumamoto University, Japan]
|
Effects of Enfuvirtide resistant mutations on the
sensitivity to neutralizing antibodies |
11:05-11:25 y20z |
O-35
-3B |
Ryusho Kariya
[Kumamoto University, Japan]
|
HAMLET and BAMLET induces cell death of Primary Effusion
Lymphoma |
11:25-11:45 y20z |
O-36
-3B |
Junko Tanuma
[NCGM, Japan]
|
Stably low prevalence of drug resistant HIV transmission
while antiretroviral therapy was scaling up in Southern Vietnam: 2008-2012 |
| 11:45-12:05 y20z |
O-37
-3B |
Kazuhiro Matsuoka
[Nagoya Medical Center, Japan] |
Cross-Resistance Mutation Patterns in Non-Nucleoside
Reverse Transcriptase Inhibitors Rilpivirine and Etravirine in Clinical
Isolates |